BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32885984)

  • 1. Using the primary site as a prognostic tool for nodal mantle cell lymphoma: a SEER-based study.
    Kamel MG; El-Qushayri AE; Sayed AK; Huy NT
    J Comp Eff Res; 2020 Aug; 9(12):861-876. PubMed ID: 32885984
    [No Abstract]   [Full Text] [Related]  

  • 2. Using primary site as a predictor of survival in mantle cell lymphoma.
    Ambinder AJ; Shenoy PJ; Nastoupil LJ; Flowers CR
    Cancer; 2013 Apr; 119(8):1570-7. PubMed ID: 23341329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extranodal Head and Neck Mantle Cell Lymphoma: Characteristics, Treatment, and Survival.
    Breen CT; Chao J; Mehra S; Kohli N
    Ann Otol Rhinol Laryngol; 2022 Apr; 131(4):412-419. PubMed ID: 34137303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in survival for patients with mantle cell lymphoma in the era of novel agents in 1995-2013: Findings from Texas and national SEER areas.
    Fu S; Wang M; Li R; Lairson DR; Zhao B; Du XL
    Cancer Epidemiol; 2019 Feb; 58():89-97. PubMed ID: 30528835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index.
    Sarkozy C; Terré C; Jardin F; Radford I; Roche-Lestienne C; Penther D; Bastard C; Rigaudeau S; Pilorge S; Morschhauser F; Bouscary D; Delarue R; Farhat H; Rousselot P; Hermine O; Tilly H; Chevret S; Castaigne S
    Genes Chromosomes Cancer; 2014 Jan; 53(1):106-16. PubMed ID: 24249260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival trends in mantle cell lymphoma in the United States over 16 years 1992-2007.
    Chandran R; Gardiner SK; Simon M; Spurgeon SE
    Leuk Lymphoma; 2012 Aug; 53(8):1488-93. PubMed ID: 22242824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
    Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
    J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of the biological behavior and grade among cases with mantle cell lymphoma.
    Hashimoto Y; Nakamura N; Kuze T; Abe M
    Leuk Lymphoma; 2002 Mar; 43(3):523-30. PubMed ID: 12002755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.
    Bomben R; Ferrero S; D'Agaro T; Dal Bo M; Re A; Evangelista A; Carella AM; Zamò A; Vitolo U; Omedè P; Rusconi C; Arcaini L; Rigacci L; Luminari S; Piccin A; Liu D; Wiestner A; Gaidano G; Cortelazzo S; Ladetto M; Gattei V
    Haematologica; 2018 May; 103(5):849-856. PubMed ID: 29472356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
    Shah BK; Khanal A
    Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database.
    Salek D; Vesela P; Boudova L; Janikova A; Klener P; Vokurka S; Jankovska M; Pytlik R; Belada D; Pirnos J; Moulis M; Kodet R; Michal M; Janousova E; Muzik J; Mayer J; Trněný M
    Leuk Lymphoma; 2014 Apr; 55(4):802-10. PubMed ID: 23772666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
    Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
    J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of cdc2 is useful in predicting survival in patients with mantle cell lymphoma.
    Hui D; Reiman T; Hanson J; Linford R; Wong W; Belch A; Lai R
    Mod Pathol; 2005 Sep; 18(9):1223-31. PubMed ID: 15933757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
    Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report.
    Jo JC; Kim SJ; Lee HS; Eom HS; Lee SI; Park Y; Lee JO; Lee Y; Yhim HY; Yang DH; Byun JM; Kang HJ; Kim HJ; Shin HJ; Yoo KH; Suh C;
    Ann Hematol; 2020 Feb; 99(2):223-228. PubMed ID: 31853704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index.
    Møller MB; Pedersen NT; Christensen BE
    Br J Haematol; 2006 Apr; 133(1):43-9. PubMed ID: 16512827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
    [No Abstract]   [Full Text] [Related]  

  • 19. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
    Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
    Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.
    Orchard J; Garand R; Davis Z; Babbage G; Sahota S; Matutes E; Catovsky D; Thomas PW; Avet-Loiseau H; Oscier D
    Blood; 2003 Jun; 101(12):4975-81. PubMed ID: 12609845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.